Answer
The safety and efficacy of brentuximab vedotin (Adcetris) have not been established in children under 18, and no dosing recommendation can be made.
Sources for this answer
- Adcetris 50 mg powder for concentrate for solution for infusionTakeda UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 33Document updated
Sources checked